[Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
Gasser
U S
US
Gasser
T
T
D000544:Alzheimer Disease / Q000188:drug therapy*; D002219:Carbamates / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D016001:Confidence Intervals; D000077265:Donepezil; D005702:Galantamine / Q000627:therapeutic use; D020441:Ginkgo biloba; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000627:therapeutic use; D018697:Nootropic Agents / Q000627:therapeutic use; D010277:Parasympathomimetics / Q000627:therapeutic use; D048448:Phenylcarbamates; D008517:Phytotherapy; D010880:Piperidines / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D016032:Randomized Controlled Trials as Topic; D000068836:Rivastigmine
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D007189:Indans; D018696:Neuroprotective Agents; D018697:Nootropic Agents; D010277:Parasympathomimetics; D048448:Phenylcarbamates; D010880:Piperidines; D010919:Placebos; D005702:Galantamine; D000077265:Donepezil; D000068836:Rivastigmine